Healthcare Triangle, Inc. (HCTI) Stock Price & Analysis
Healthcare Triangle, Inc. (HCTI) rose 4.42% to USD 2.36 as of June 10, 2026 at 03:38 UTC, according to Nexqual real-time market data.
HCTI last closed at USD 2.26; the session ranged USD 2.26–2.4 on volume of 34,287 shares. Market capitalization is $4.79M, with a 52-week range of USD 2.06–1,299.78 (NCM). Source: Nexqual, June 10, 2026 at 03:38 UTC.
Key Statistics (as of June 10, 2026 at 03:38 UTC)
| Price | USD 2.36 |
|---|---|
| Change | ▲ 4.42% (up) |
| Previous Close | USD 2.26 |
| Open | USD 2.35 |
| Day Range | USD 2.26 – 2.4 |
| 52-Week Range | USD 2.06 – 1,299.78 |
| Volume | 34,287 shares |
| Market Cap | $4.79M |
| Exchange | NCM |
Technical Analysis (HCTI)
Nexqual's technical model rates HCTI "SELL" based on 1 bullish and 4 bearish signals across 124 daily candles, as of June 10, 2026 at 03:38 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 47.89 (neutral) |
| vs SMA50 | Below (USD 2.38) |
| MACD | -0.06 (negative) |
Analyst Ratings (HCTI)
Wall Street analysts rate HCTI "None" based on 1 analysts, with a mean price target of USD 5 (range USD 5–5), per Nexqual as of June 10, 2026 at 03:38 UTC.
| Consensus Rating | None |
|---|---|
| Analyst Count | 1 |
| Mean Target | USD 5 |
| High Target | USD 5 |
| Low Target | USD 5 |
| Buy / Hold / Sell | 0 / 0 / 0 |
Earnings (HCTI)
| EPS Estimate | USD -3.43 |
|---|---|
| Revenue Estimate | $10.35M |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2025-12-31 | USD -18.5 vs est -12 ▼ miss |
| 2025-09-30 | USD -25.2 vs est -13.2 ▼ miss |
Source: Nexqual, June 10, 2026 at 03:38 UTC.
Financials & Fundamentals (HCTI)
| Total Revenue | $20.04M |
|---|---|
| Revenue Growth (YoY) | +166.10% |
| Gross Margin | +19.73% |
| Operating Margin | -36.76% |
| Profit Margin | -69.72% |
| ROE | -45.61% |
| Debt / Equity | 20.63 |
| Current Ratio | 0.9 |
| Total Cash | $4.32M |
| Total Debt | $10.87M |
| Free Cash Flow | $-9.90M |
Source: Nexqual, June 10, 2026 at 03:38 UTC.
Financial Health Score (HCTI)
Nexqual rates Healthcare Triangle, Inc.'s overall financial health "Mixed" across five dimensions, as of June 10, 2026 at 03:38 UTC.
| Growth | Strong — Revenue +166% YoY (latest Q) |
|---|---|
| Profitability | Weak — Not yet profitable — scaling phase |
| Balance Sheet | Solid — $4M cash vs $11M debt |
| Cash Flow | Weak — FCF negative: -$10M, burning cash |
| Efficiency | Critical — ROE -46%, ROA -16.3% |
Ownership (HCTI)
| Insider Ownership | +0.01% |
|---|---|
| Institutional Ownership | +5.49% |
| Shares Outstanding | 2.03M |
| Float | 2.03M |
| Short % of Float | +4.53% |
Source: Nexqual, June 10, 2026 at 03:38 UTC.
Leadership (HCTI)
Healthcare Triangle, Inc. is led by David Ayanoglou (age 45), Chief Financial Officer, per Nexqual as of June 10, 2026 at 03:38 UTC.
| Chief Financial Officer | David Ayanoglou (age 45) |
|---|---|
| Principal Executive Officer (SEC), COO & Executive Director | Sujatha Ramesh (age 54) |
Major Backers & Investors (HCTI)
Notable institutional backers of Healthcare Triangle, Inc. include UBS Group AG, Morgan Stanley, Virtu Financial LLC, according to Nexqual as of June 10, 2026 at 03:38 UTC.
Active Investors
| Investor | Stake |
|---|---|
| UBS Group AG | 2.01% |
| Morgan Stanley | 1.01% |
| Virtu Financial LLC | 0.72% |
| Fidelity | 0.62% |
| Bank of Montreal /CAN/ | 0.49% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Geode Capital | 0.62% |
Source: Nexqual, June 10, 2026 at 03:38 UTC.
From Healthcare Triangle, Inc.'s Latest SEC 10-K Filing (filed 2026-04-15)
Key Strengths & Strategy (as disclosed to the SEC)
- Healthcare Triangle, Inc., a healthcare information technology company, focuses on advancing solutions in the sectors of cloud services, data science, and professional and managed services for the electronic health record, and healthcare and life sciences industry.
- It provides a suite of software, solutions, platforms, and services that enables healthcare and pharma organizations to deliver personalized healthcare, precision medicine, advances in drug discovery, development and efficacy, collaborative research and development, respond to evidence, and accelerate their digital transformation.
- The company's software platforms include CloudEz, an enterprise multi-cloud transformation and management platform that enables customers to manage their cloud infrastructure in private, hybrid, and public cloud infrastructures; DataEz, a cloud-based data analytics and data science platform for the data analytics and data science requirements of life sciences/pharmaceutical and healthcare provider organizations; Blockchain infrastructure; and Cybersecurity navigator.
- It also provides Readabl.AI, a Software-as-a-Service solution that uses public cloud artificial intelligence and machine learning to recognize and extract healthcare information from documents, faxes, and narrative reports.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| IXHL | Incannex Healthcare Inc. | USD 3.67 | ▲ 25.68% |
| SPRC | SciSparc Ltd. | USD 9.31 | ▼ 18.62% |
| SMX | SMX (Security Matters) Public L | USD 13.09 | ▲ 0.31% |
| SKYA | SkyAI, Inc. | USD 1.16 | ▼ 4.13% |
| FRGT | Freight Technologies, Inc. | USD 4.5 | ▲ 6.64% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 03:38 UTC. This page is informational and not investment advice.